293 related articles for article (PubMed ID: 16110886)
1. Novel vaccines from biotechnology.
Rogan D; Babiuk LA
Rev Sci Tech; 2005 Apr; 24(1):159-74. PubMed ID: 16110886
[TBL] [Abstract][Full Text] [Related]
2. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
[TBL] [Abstract][Full Text] [Related]
3. [Biotechnology for the benefit of vaccination against viral diseases: a review].
van Oirschot JT
Tijdschr Diergeneeskd; 2002 Jan; 127(1):7-16. PubMed ID: 11795035
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in veterinary vaccinology.
Shams H
Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
[TBL] [Abstract][Full Text] [Related]
5. New technology for improved vaccine safety and efficacy.
Roth JA; Henderson LM
Vet Clin North Am Food Anim Pract; 2001 Nov; 17(3):585-97, vii. PubMed ID: 11692510
[TBL] [Abstract][Full Text] [Related]
6. Marker vaccines and the impact of their use on diagnosis and prophylactic measures.
Vannie P; Capua I; Le Potier MF; Mackay DK; Muylkens B; Parida S; Paton DJ; Thiry E
Rev Sci Tech; 2007 Aug; 26(2):351-72. PubMed ID: 17892157
[TBL] [Abstract][Full Text] [Related]
7. Overview of marker vaccine and differential diagnostic test technology.
Henderson LM
Biologicals; 2005 Dec; 33(4):203-9. PubMed ID: 16257545
[TBL] [Abstract][Full Text] [Related]
8. Biotechnology and DNA vaccines for aquatic animals.
Kurath G
Rev Sci Tech; 2008 Apr; 27(1):175-96. PubMed ID: 18666487
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases.
Gay CG; Salt J; Balaski C
Dev Biol (Basel); 2003; 114():243-50. PubMed ID: 14677694
[TBL] [Abstract][Full Text] [Related]
10. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
Foley PL; Hill RE
Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
[TBL] [Abstract][Full Text] [Related]
11. OIE standards for vaccines and future trends.
Edwards S
Rev Sci Tech; 2007 Aug; 26(2):373-8. PubMed ID: 17892158
[TBL] [Abstract][Full Text] [Related]
12. Genomics and vaccine development.
Gay CG; Zuerner R; Bannantine JP; Lillehoj HS; Zhu JJ; Green R; Pastoret PP
Rev Sci Tech; 2007 Apr; 26(1):49-67. PubMed ID: 17633293
[TBL] [Abstract][Full Text] [Related]
13. Production of veterinary vaccines in the Sudan.
Babiker SH
Berl Munch Tierarztl Wochenschr; 1996 Jan; 109(1):8-9. PubMed ID: 8593158
[TBL] [Abstract][Full Text] [Related]
14. Veterinary vaccines for animal and public health.
Pastoret PP; Jones P
Dev Biol (Basel); 2004; 119():15-29. PubMed ID: 15742615
[TBL] [Abstract][Full Text] [Related]
15. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. [New technologies for vaccine development].
Leclerc C
Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228
[TBL] [Abstract][Full Text] [Related]
18. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.
van Drunen Littel-van den Hurk S
Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163
[TBL] [Abstract][Full Text] [Related]
19. Animal vaccination and the veterinary pharmaceutical industry.
O'Brien D; Zanker S
Rev Sci Tech; 2007 Aug; 26(2):471-7. PubMed ID: 17892167
[TBL] [Abstract][Full Text] [Related]
20. The need for new vaccines.
Taylor K; Nguyen A; Stéphenne J
Vaccine; 2009 Dec; 27 Suppl 6():G3-8. PubMed ID: 20006137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
